Top Tweets for #stellar304
Really enjoyed this conversation with @maughanonc on real-world treatment patterns in papillary RCC.
We discussed first-line strategies and how upcoming trials may help answer some of the key questions.
#PAPMET2 #SAMETA #STELLAR304
💬 In this video, Dr. Ben Maughan (@maughanonc) speaks with Dr. @mzugman on his research on real-world treatment patterns in papillary #RCC, outlining how his team used a national dataset to compare first-line approaches: https://t.co/KtjdPUvQI3
Can't wait to see results from the P3 studies in nccRCC. I think that we owe it to our pts to hold therapies in this space to the same rigorous bar we do therapies for ccRCC. #SAMETA & #STELLAR304 (irrespective of the results) prove that we CAN do P3 trials in these rare diseases. @uromigos @brian_rini @tompowles1
Research in papillary cancer is moving quickly with 2 randomised trial complete (savolitinib/durvalumab in MET +ves & Zanzalintinib+nivolumab). Here @lalaniMD describes in his Uromigos video current & future treatment based around VEFG & PD-1 therapy @OncoAlert #UromigosLive
Until we have randomized studies, we will not truly understand the contribution of IO in TKI/IO combinations for non-clear cell #kidneycancer. #STELLAR304 & #SAMETA are v imp P3 trials that have yet to read out - in the meantime, please consider supporting @SWOG #PAPMET2, led by @maughanonc @huntsmancancer.
Highlighting ongoing trials #SAMETA #stellar304 and - I would add #PAPMET2 — for papillary #kidneycancer. Doublets coming for papillary RCC! @Uromigos #UromigosLive24
@montypal @caseccc @SWOG @GUONCGarciaJA @neerajaiims @AndreaNecchi @PGrivasMDPhD @MyriamChalabi @apolo_andrea @NazliDizman @VivekSubbiah @PavlosMsaouel Thank you @montypal !! A lot of your efforts are changing the managements of these tumors for the better. More to come on that! #PAPMET2 #STELLAR304 and others
So what are those #randomized trials? I've summarized them here. #PAPMET2, #STELLAR304, #SAMETA & several others require our attention as a community. It's imperative that we definitively establish the role of TKI/IO regimens for #papillary #kidneycancer & other #nonclear cell types. (9/n)
Absolutely loved talks from @DrRanaMcKay & @tompowles1. Tom's graphic (see below) puts together the data we have in nccRCC nicely within 1 slide - & underscores the need for large, randomized studies. We need to consider studies like #STELLAR304 & @PAPMET2 to move the field forward. @ASCO #GU24
👉Zanzalintinib ha mostrato risultati interessanti nel #ccRCC. L'UOC di oncologia del #PoliclinicoGemelli è pronta ad offrire questo nuovo farmaco ai pazienti con #tumoredelrene non a cellule chiare nello studio #STELLAR304. @adnk_salute @saluteoggiblog
Incredibly promising data for Zanzalintinib in patients with kidney cancer - @montypal
@KidneyCancer
#Cabozantinib #Cancer #CityOfHope #Zanzalintinib #IKCSNA23 #KidneyCancer #OncoDaily #Oncology #STELLAR304
https://t.co/bxCQrPvfVf
Exciting news at #IKCSNA23 by @montypal on #zanzalintinib for #kidneycancer! Promising data in ccRCC pts, showing impressive ORR 38%, DCR 88% & notable safety profile. Noteworthy responses in those previously treated with cabo. Looking forward to #STELLAR304 study. #oncology
Very excited to share with you incredibly promising data for #zanzalintinib (#XL092) in patients with #kidneycancer. A million thanks to @kidneycancer for allowing us to present this data in a highlighted oral session at #IKCSNA23! See my slides/thoughts here: (1/9)
Honored to present my poster on Hispanic kidney cancer incidence patterns by median household income at #IKCSNA23! @KidneyCancer and connect with amazing patients advocates and @montypal.
👉 Exciting data on #Zanzalintinib (#XL092) in patients with ccRCC #STELLAR304
LOTS more to come with #zanzalintinib across tumor types. My personal plea is that you consider #STELLAR304, a study that will hopefully introduce a new standard for non-clear cell #kidneycancer. Come by our poster here at #IKCSNA23! (9/9)
RR continue to climb in @ChungHanLee3 @motzermd @MSKCancerCenter trial of cabo/nivo in nccRCC. Need to establish role of TKI/IO in nccRCC - best way to do this is to support trials like @SWOG 2200 & #STELLAR304. @uromigos @brian_rini @tompowles1 @ASCO #ASCO23
Ab#4537 #ASCO23 @ASCO : updated results from Ph 2 study of nivolumab + cabozantinib in pts with non-clear cell RCC #kidneycancer➡️ORR 54% in 1st line Rx, 36% in 2nd line Rx 👉https://t.co/d9XJ3UaadV
@motzermd @kidneycan @OncoAlert @urotoday
Terrific commentary from @jackiebrown_MD @basselna & @bilenma in @JCO_ASCO. #CALYPSO takes an impt first step in assessing a selective METi w IO; kudos to @crisuarez08 & @tompowles1. Keen on seeing how @SWOG #PAPMET2, #STELLAR304, #PAXIPEM & #SAMETA pan out!
honored for the chance to place the v important CALYPSO trial within the papillary RCC landscape, MET-driven and otherwise @bilenma @BasselNazha - congrats #CristinaSuárez, @tompowles1, & team!
https://t.co/zLiIErEoxa
Last Seen Hashtags on Sotwe
hijabtoge
Seen from Indonesia
darkzadie https
Seen from Poland
原创作品
Seen from Thailand
沙耶の唄
Seen from United States
びー
Seen from United Arab Emirates
momsonn(*)* ((())) filter:videos
Seen from India
싸지
Seen from Korea
momson OR #nolimit
Seen from Ecuador
baitservices
Seen from United Kingdom
teeNager(***)******+filter:native_video
Seen from Canada
Most Popular Users
Elon Musk 
@elonmusk
241.2M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.9M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.3M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.5M followers
KATY PERRY
@katyperry
89.1M followers
Taylor Swift
@taylorswift13
83M followers
Lady Gaga
@ladygaga
74.5M followers
Virat Kohli
@imvkohli
72M followers
Kim Kardashian
@kimkardashian
70.5M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
64.9M followers
Bill Gates
@billgates
64.6M followers
The Ellen Show
@theellenshow
62.4M followers
Selena Gomez
@selenagomez
62.1M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers